nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
|
Zimovetz, Evelina A. |
|
|
19 |
1 |
p. 21-35 |
artikel |
2 |
A “healthy immigrant effect” or a “sick immigrant effect”? Selection and policies matter
|
Constant, Amelie F. |
|
|
19 |
1 |
p. 103-121 |
artikel |
3 |
A methodological framework for assessing agreement between cost-effectiveness outcomes estimated using alternative sources of data on treatment costs and effects for trial-based economic evaluations
|
Achana, Felix |
|
|
19 |
1 |
p. 75-86 |
artikel |
4 |
Competition and quality indicators in the health care sector: empirical evidence from the Dutch hospital sector
|
Croes, R. R. |
|
|
19 |
1 |
p. 5-19 |
artikel |
5 |
Competition in pharmaceuticals: more product- than price-oriented?
|
Garattini, Livio |
|
|
19 |
1 |
p. 1-4 |
artikel |
6 |
Corruption costs lives: evidence from a cross-country study
|
Li, Qiang |
|
|
19 |
1 |
p. 153-165 |
artikel |
7 |
Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy
|
Restelli, Umberto |
|
|
19 |
1 |
p. 37-44 |
artikel |
8 |
Good jobs, good pay, better health? The effects of job quality on health among older European workers
|
Henseke, Golo |
|
|
19 |
1 |
p. 59-73 |
artikel |
9 |
Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial
|
Michalowsky, Bernhard |
|
|
19 |
1 |
p. 87-102 |
artikel |
10 |
Investigating social inequalities in older adults’ dentition and the role of dental service use in 14 European countries
|
Shen, Jing |
|
|
19 |
1 |
p. 45-57 |
artikel |
11 |
Patient preferences: a Trojan horse for evidence-based medicine?
|
Gandjour, Afschin |
|
|
19 |
1 |
p. 167-172 |
artikel |
12 |
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries
|
Angelis, Aris |
|
|
19 |
1 |
p. 123-152 |
artikel |
13 |
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries
|
Angelis, Aris |
|
|
19 |
1 |
p. 123-152 |
artikel |